ArticleMedical oncology (Northwood, London, England)2014

Elevated pretreatment serum concentration of YKL-40: an independent prognostic biomarker for poor survival in patients with colorectal cancer.

Xiaomei Liu et al.PubMed ↗Publisher ↗

No numbers read from the abstract.